The antifungal agents most frequently used in prophylaxis and treatment are amphotericin B (and its new lipid forms) and azoles such as fluconazole, itraconazole, and more recently voriconazole. This review assesses the role of itraconazole in paediatric haematology/oncology practice. Its broader spectrum of activity and availability in oral and intravenous forms allow a flexible approach in the management of fungal infections.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1719494 | PMC |
| http://dx.doi.org/10.1136/adc.88.3.258 | DOI Listing |
Publication Analysis
Top Keywords
role itraconazole
8
itraconazole haematology/oncology
4
haematology/oncology antifungal
4
antifungal agents
4
agents frequently
4
frequently prophylaxis
4
prophylaxis treatment
4
treatment amphotericin
4
amphotericin lipid
4
lipid forms
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!